NEW YORK (GenomeWeb News) – Belgian molecular diagnostics firm Multiplicom today said it has been awarded €200,000 ($250,000) to develop a blood-based non-invasive fetal aneuploidy test.

The grant from the Flemish agency for Innovation by Science and Technology will be used by Multiplicom to develop the test based on its Multiplex Amplification of Specific Targets for Resequencing workflow. The PCR-based test detects copy number variations in chromosomes 21, 18, 13, X and Y in fetal DNA isolated from the mother's blood.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.